Track Beta Bionics's other current liabilities ($25M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Beta Bionics (BBNX) currently reports a other current liabilities of $25M as of September 2026. That compares with $18M in the prior-year period — up 40.1% year over year. Use the charts on this page to explore Beta Bionics's other current liabilities history and peer comparisons.
Beta Bionics's other current liabilities increased from $18M to $25M — a 40.1% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Beta Bionics reported $25M in other current liabilities as of September 2026. That compares with $18M in the prior-year period — up 40.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current other current liabilities of $25M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Beta Bionics, and consider following BBNX for alerts when major investors trade the stock.